- Home
- ARMP vs IDN Comparison
ARMP vs IDN Comparison
Compare ARMP & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- IDN
- Stock Information
- Founded
- ARMP N/A
- IDN 1994
- Country
- ARMP United States
- IDN United States
- Employees
- ARMP N/A
- IDN N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- IDN Computer Software: Prepackaged Software
- Sector
- ARMP Health Care
- IDN Technology
- Exchange
- ARMP Nasdaq
- IDN Nasdaq
- Market Cap
- ARMP 104.3M
- IDN 101.6M
- IPO Year
- ARMP N/A
- IDN 1999
- Fundamental
- Price
- ARMP $3.12
- IDN $5.23
- Analyst Decision
- ARMP Strong Buy
- IDN Strong Buy
- Analyst Count
- ARMP 1
- IDN 3
- Target Price
- ARMP $9.00
- IDN $6.17
- AVG Volume (30 Days)
- ARMP 7.8K
- IDN 133.9K
- Earning Date
- ARMP 11-12-2025
- IDN 11-12-2025
- Dividend Yield
- ARMP N/A
- IDN N/A
- EPS Growth
- ARMP N/A
- IDN N/A
- EPS
- ARMP N/A
- IDN N/A
- Revenue
- ARMP $6,868,000.00
- IDN $20,662,000.00
- Revenue This Year
- ARMP $8.43
- IDN $9.73
- Revenue Next Year
- ARMP N/A
- IDN $11.75
- P/E Ratio
- ARMP N/A
- IDN N/A
- Revenue Growth
- ARMP 84.67
- IDN 7.12
- 52 Week Low
- ARMP $0.90
- IDN $1.92
- 52 Week High
- ARMP $3.14
- IDN $6.49
- Technical
- Relative Strength Index (RSI)
- ARMP 62.83
- IDN 46.65
- Support Level
- ARMP $2.94
- IDN $4.98
- Resistance Level
- ARMP $3.07
- IDN $5.51
- Average True Range (ATR)
- ARMP 0.08
- IDN 0.24
- MACD
- ARMP -0.01
- IDN -0.05
- Stochastic Oscillator
- ARMP 97.96
- IDN 26.60
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.